BioXcel Therapeutics, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
BTAI Company Description
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
BTAI Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view BTAI Smart Score
Score Breakdown
BTAI Company Description
Show More
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of BTAI by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by BTAI's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on BTAI's company Twitter account
WallStreetBets
Number of mentions of BTAI in WallStreetBets Daily Discussion
BTAI News
Recent insights relating to BTAI
CNBC Recommendations
Recent picks made for BTAI stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in BTAI
Corporate Flights
Flights by private jets registered to BTAI
Our Analysis